Next Article in Journal
Automatic Identification of Down Syndrome Using Facial Images with Deep Convolutional Neural Network
Next Article in Special Issue
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak
Previous Article in Journal
Site-Of-Care Viscoelastic Assay in Major Trauma Improves Outcomes and Is Cost Neutral Compared with Standard Coagulation Tests
Previous Article in Special Issue
Complications in Idiopathic Pulmonary Fibrosis: Focus on Their Clinical and Radiological Features
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Multidisciplinary Approach to Interstitial Lung Diseases: Nothing Is Better than All of Us Together

1
Department of Clinical and Experimental Medicine, University of Catania, Regional Referral Center for Rare Lung Diseases, University Hospital “Policlinico–Vittorio Emanuele”, via S. Sofia 78, 95123 Catania, Italy
2
Department of Medical Surgical Sciences and Advanced Technologies, Radiology Unit I, University Hospital “Policlinico–Vittorio Emanuele”, 95123 Catania, Italy
*
Author to whom correspondence should be addressed.
Submission received: 6 July 2020 / Accepted: 7 July 2020 / Published: 17 July 2020
(This article belongs to the Special Issue Clinical and Radiological Features of Interstitial Lung Diseases)

Abstract

:
Interstitial Lung Diseases (ILDs) are a large family of disorders characterized by inflammation and/or fibrosis of areas of the lung dedicated to gas exchange. In this Special Issue entitled “Clinical and Radiological Features of Interstitial Lung Diseases”, we collected a series of contributions in which a multidisciplinary approach was crucial for the correct diagnostic assessment of ILD. Sharing knowledge between different specialties can significantly improve diagnostic approaches and the management of ILD patients.

Interstitial Lung Diseases (ILDs) are a large family of disorders characterized by inflammation and/or fibrosis of areas of the lung dedicated to gas exchange. The impairment of lung parenchyma causes the occurrence of symptoms, and in some ILDs, such as idiopathic pulmonary fibrosis (IPF), it may lead to respiratory failure and death. Some ILDs, including IPF and sarcoidosis, are idiopathic, others such as hypersensitivity pneumonia and drug-induced ILDs recognize specific etiologic agents, some others are instead associated with systemic diseases, as in the case of connective tissue diseases (CTD-ILDs) [1]. ILDs represent about 20% of lung diseases routinely seen by pulmonologists during their daily activity, and their number, due to the improvement of the diagnostic procedures, is increasing [2]. It is also plausible that exposures to known risk factors such as smoking, but also new and unknown environmental and professional agents or drugs may be responsible for this alarming trend. All this may explain the increasing scientific attention to ILDs by researchers and clinicians, attracted by the wide array of “intriguing” basic and clinical issues associated with pathogenesis, diagnosis, follow-up, and treatment of this group of diseases. In particular, the large number of clinical, functional, and radiological overlaps among ILDs makes their diagnosis extremely difficult and challenging. For these reasons, a multidisciplinary approach to the diagnosis of ILDs is strongly recommended, representing the best way to improve the diagnostic accuracy of these diseases [3]. In this Special Issue, dedicated to the “Clinical and Radiological Features of Interstitial Lung Diseases”, the two editors present a series of articles where pulmonologists, radiologists, rheumatologists, and other experts, put their knowledge together with the unique aim of underlining specific clinical and radiological aspects of ILDs that might be useful to the diagnostic approach to ILDs for a larger audience of clinicians. Some of the articles in this Special Issue are opportunely dedicated to High-Resolution Computed Tomography (HRCT), one of the most important diagnostic tools in ILDs. In most ILDs, symptoms are non-specific, making the differential diagnosis particularly difficult. Only in some cases is the radiological pattern typical for a specific disease, whereas in many others, the interpretation of the radiological picture is more difficult and needs to be reviewed by an expert lung radiologist. In any case, the interpretations based on qualitative evaluations of HRCT are limited by a visual analysis, which is time-consuming, and above all, subjective. Stefano et al. show in this issue that computer-based analysis might be a useful tool for the radiological assessment of patients with IPF. In particular, they found a specific parameter measuring the percentage of normally attenuated lungs that, together with qualitative HRCT assessment and pulmonary function test, increases the accuracy of the diagnostic process in IPF [4]. The whole matter is further complicated by the pleiomorphisms of radiological presentations in different ILDs, but also in the same disease at different stages. Tiralongo et al. describe the evolution of morphological patterns at HRCT in cryptogenic organizing pneumonia in response to treatment with steroids [5]. Aquilina et al. have instead focused their attention on cystic lung diseases, one of the most typical radiological presentations of ILDs [6]. Their study aims to offer a practical guide to radiologists and pulmonologists for an easier interpretation of these particular lesions. To do this, the different cystic lesions were effectively and nicely described through free-hand drawings that are related to HRCT images, helping to recognize the correct differential diagnosis between similar conditions. Sambataro et al. observed that ground-glass opacities at HRCT correlate with disease activity in Systemic Sclerosis (SSc), whereas the fibrosis grade correlated with disease duration and pulmonary artery pressure [7]. Besides, they observed that the quantification of pulmonary involvement using the Wells score could be a useful tool for assessing the appropriate treatment in SSc patients. Remaining in the field of SSc and autoimmune diseases, Sambataro et al. also present some interesting data on nailfold videocapillaroscopy, described in this manuscript as a useful tool for the recognition of SSc and idiopathic inflammatory myopathies in patients with ILDs [8]. Furthermore, in a different article of this Special Issue, the role of the rheumatologist within the multidisciplinary team is underlined, and how a set of first-line clinical, laboratory, and instrumental tests might increase the frequency of diagnosis of autoimmune diseases among patients with ILD [9]. In another interesting paper, Galioto et al. described the most peculiar clinical and radiological features of complications in IPF [10]. The last two articles, distinct from all the others, are dedicated to the possible relationship between the radiological patterns of sarcoidosis and its clinical outcome, and the last article is an interesting description of HRCT patterns in drug-induced ILDs [11,12].The diagnosis of drug-induced-ILDs, as a consequence of the introduction of new drug therapies, is constantly increasing. Unfortunately, the morphological HRCT patterns are not specific for a given drug. Therefore the diagnosis should be based on clinical-anamnestic data, radiological, and laboratory features, confirming once again the need for a multidisciplinary team approach for the diagnosis of ILD.
All articles of this Special Issue are comprehensive and innovative in their approaches, addressing practical and still controversial or unresolved clinical problems related to the diagnosis, follow-up, and prognosis of ILDs. The two editors, Stefano Palmucci and Sebastiano Torrisi, both have the merit to involve and coordinate in this Special Issue, a number of young clinicians and experts. Looking at the list of authors who contributed to the different articles, it is nice to note the variety of their specialties: Biologists, physicists, immunologists, rheumatologists, radiologists, internists, computer scientists, and pulmonologists have all contributed to the success of this issue dedicated to ILDs. The participation and commitment of young experts to this group of diseases, coming from very different scientific settings, confirm the relevance and the broad clinical interest for this important chapter of the respiratory diseases.

Funding

This research received no external funding.

Conflicts of Interest

C.V. is part of the F. Hoffmann-La Roche Ltd. Scientific board. He has received consulting fees and/or speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi, F. Hoffmann-La Roche Ltd., and Menarini.

Abbreviations

CTDConnective Tissue Disease
HRCTHigh-Resolution Computed Tomography
ILDInterstitial Lung Diseases
IPFIdiopathic Pulmonary Fibrosis
MDTMultidisciplinary Team
SScSystemic Sclerosis.

References

  1. Travis, W.D.; Costabel, U.; Hansell, D.M.; King, T.E., Jr.; Lynch, D.A.; Nicholson, A.G.; Ryerson, C.J.; Ryu, J.H.; Selman, M.; Wells, A.U.; et al. ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am. J. Respir. Crit. Care Med. 2013, 188, 733–748. [Google Scholar] [CrossRef] [PubMed]
  2. Zibrak, J.D.; Price, D. Interstitial Lung Disease: Raising the index of suspicion in Primary care. NPJ Prim. Care Respir. Med. 2014, 24, 14054. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Furini, F.; Carnevale, A.; Casoni, G.; Guerrini, G.; Cavagna, L.; Govoni, M.; Scirè, C.A. The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the current evidence and future perspectives. Front. Med. 2019, 6, 246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Stefano, A.; Gioè, M.; Russo, G.; Palmucci, S.; Torrisi, S.E.; Bignardi, S.; Basile, A.; Comelli, A.; Benfante, V.; Sambataro, G.; et al. Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT. Diagnostics 2020, 10, 306. [Google Scholar] [CrossRef] [PubMed]
  5. Tiralongo, F.; Palermo, M.; Distefano, G.; Vancheri, A.; Sambataro, G.; Torrisi, S.E.; Galioto, F.; Ferlito, A.; Fazio, G.; Foti, P.V.; et al. Cryptogenic Organizing Pneumonia: Evolution of morphologicalpatterns ossesse by HRCT. Diagnostics 2020, 10, 262. [Google Scholar] [CrossRef] [PubMed]
  6. Aquilina, G.; Caltabiano, D.C.; Galòioto, F.; Cancemi, G.; Pino, F.; Vancheri, A.; Vancheri, C.; Foti, P.V.; Mauro, L.A.; Basile, A. Cystic Interstitial Lung Disease: A pictorial review and a practical guide for the radiologist. Diagnostics 2020, 10, 346. [Google Scholar] [CrossRef] [PubMed]
  7. Sambataro, D.; Sambataro, G.; Pignataro, F.; Maglione, W.; Malatino, L.; Vancheri, C.; Colaci, M.; Del Papa, N. Quantification of ground glass opacities can be useful to describe disease activity in Systemic Sclerosis. Diagnostics 2020, 10, 225. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Sambataro, D.; Sambataro, G.; Libra, A.; Vignigni, G.; Pino, F.; Fagone, E.; Fruciano, M.; Gili, E.; Pignataro, F.; Del Papa, N.; et al. Nailfold Videocapillaroscopy is a useful tool to recognize definite forms of Systemic Sclerosis and Idiopathic Inflammatory Myositis in Interstitial Lung Disease patients. Diagnostics 2020, 10, 253. [Google Scholar] [CrossRef] [PubMed]
  9. Sambataro, D.; Sambataro, G.; Pignataro, F.; Zanframundo, G.; Codullo, V.; Fagone, E.; Martorana, E.; Ferro, F.; Orlandi, M.; Del Papa, N.; et al. Patients with Interstitial Lung Disease secondary to Autoimmune Diseases: How to recognize them? Diagnostics 2020, 10, 208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Galioto, F.; Palmucci, S.; Astuti, G.M.; Vancheri, A.; Distefano, G.; Tiralongo, F.; Libra, A.; Cusumano, G.; Basile, A.; Vancheri, C. Complications in Idiopathic Pulmonary Fibrosis: Focus on Their Clinical and Radiological Features. Diagnostics 2020, 10, 450. [Google Scholar] [CrossRef] [PubMed]
  11. Distefano, G.; Vancheri, A.; Palermo, M.; Tiralongo, F.; Foti, P.V.; Mauro, L.A.; Vancheri, C.; Basile, A.; Palmucci, S. Morphological patterns of sarcoidosis and clinical out come: Retrospective analysis through a Multidisciplinary approach. Diagnostics 2020, 10, 212. [Google Scholar] [CrossRef] [PubMed]
  12. Distefano, G.; Fanzone, L.; Palermo, M.; Tiralongo, F.; Cosentino, S.; Ini, C.; Galioto, F.; Vancheri, A.; Torrisi, S.E.; Mauro, L.A.; et al. HRCT patterns of drug-induced Interstitial Lung Diseases: A review. Diagnostics 2020, 10, 244. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Vancheri, C.; Basile, A. Multidisciplinary Approach to Interstitial Lung Diseases: Nothing Is Better than All of Us Together. Diagnostics 2020, 10, 488. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10070488

AMA Style

Vancheri C, Basile A. Multidisciplinary Approach to Interstitial Lung Diseases: Nothing Is Better than All of Us Together. Diagnostics. 2020; 10(7):488. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10070488

Chicago/Turabian Style

Vancheri, Carlo, and Antonio Basile. 2020. "Multidisciplinary Approach to Interstitial Lung Diseases: Nothing Is Better than All of Us Together" Diagnostics 10, no. 7: 488. https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics10070488

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop